SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001625101-19-000037
Filing Date
2019-11-07
Accepted
2019-11-07 16:18:36
Documents
4
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20191107x8k.htm 8-K 55669
2 EX-10.1 plse-20191107xex10_1.htm EX-10.1 127174
3 EX-99.1 plse-20191107xex99_1.htm EX-99.1 156158
4 EX-99.2 plse-20191107xex99_2.htm EX-99.2 25548
  Complete submission text file 0001625101-19-000037.txt   365911
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 191200596
SIC: 3841 Surgical & Medical Instruments & Apparatus